Author:
Deetanya Peerapon,Hengphasatporn Kowit,Wilasluck Patcharin,Shigeta Yasuteru,Rungrotmongkol Thanyada,Wangkanont Kittikhun
Funder
NSTDA
Chulalongkorn University
National Research Council of Thailand
Japan Agency for Medical Research and Development Department of Industrial Academic Collaboration
Subject
Computer Science Applications,Genetics,Biochemistry,Structural Biology,Biophysics,Biotechnology
Reference46 articles.
1. Coronavirus biology and replication: implications for SARS-CoV-2;V'Kovski;Nat Rev Microbiol,2020
2. From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design;Hilgenfeld;FEBS J,2014
3. Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors;Jin;Nature,2020
4. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors;Zhang;Science (New York, NY).,2020
5. Boras B, Jones RM, Anson BJ, Arenson D, Aschenbrenner L, Bakowski MA et al. 2020. Discovery of a Novel Inhibitor of Coronavirus 3CL Protease as a Clinical Candidate for the Potential Treatment of COVID-19. bioRxiv.2020.2009.2012.293498.
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献